Persistent lymphocytic leukemia (CLL) is related to immune dysfunction and an elevated danger of melanoma. For sufferers with metastatic melanoma, immunotherapy with checkpoint blocking antibodies is an ordinary of care. In sufferers with concomitant CLL and metastatic melanoma, it isn’t identified whether or not CLL would possibly affect the antimelanoma efficacy or immune-related toxicities of immune checkpoint blockade. Fifteen sufferers with domestically superior or metastatic melanoma and a concomitant prognosis of CLL who acquired pembrolizumab or ipilimumab with or with out nivolumab for the remedy of their melanoma at Memorial Sloan Kettering Most cancers Middle between January 1, 2010, and January 1, 2017, have been retrospectively recognized.
Medical traits together with absolute lymphocyte counts throughout remedy have been recorded together with a response to remedy (goal radiographic response, progression-free survival, and antagonistic occasions) for every affected person. Of 9 response-evaluable sufferers handled with ipilimumab, 3 (33%) had a partial response, 1 (11%) had steady illness, and 5 (56%) developed progressive illness. Goal tumor responses have been additionally noticed with single-agent remedy pembrolizumab and with mixture remedy of nivolumab and ipilimumab. Grade Three or four toxicity was noticed in 6 of 15 sufferers (40%), together with diarrhea, transaminitis, rash, and hemolytic anemia. Though our retrospective evaluation was restricted, there was no proof that CLL responded to the checkpoint blockade. This case collection demonstrates that ipilimumab, pembrolizumab, and mixed ipilimumab and nivolumab therapies present scientific exercise in sufferers with melanoma and concomitant CLL, at charges per these beforehand reported.
This inhabitants might warrant nearer surveillance for hematologic immune-related toxicities comparable to autoimmune hemolytic anemia. Dedication of human immunodeficiency virus-1 (HIV-1) genotypes and identification of antiretroviral drug-resistant mutations. Amongst remedy naïve HIV sufferers in Jazan, Saudi Arabia. HIV is a serious public well being drawback. HIV genotyping and antiretroviral resistance testing is a crucial information for higher administration of treatment-naive. Antiretroviral resistance testing earlier than beginning of remedy routine results in a greater virological response. A complete of 57 samples of treatment-naive sufferers have been collected from King Fahd Central Hospital in Jazan, Saudi Arabia. Samples have been examined for HIV-1 antibodies, western blot, viral load, HIV-1 genotypes by means of direct sequencing, and antiretroviral resistance testing.
Novel Auristatins with Excessive Bystander and Cytotoxic Actions in Drug-Efflux Constructive Tumor Fashions
Auristatins, a category of clinically validated anti-tubulin brokers utilized as payloads in antibody-drug conjugates, are typically labeled by their membrane permeability and the extent of cytotoxic bystander exercise on neighboring cells after focused supply. The medication usually fall inside two classes: membrane permeable monomethyl auristatin E (MMAE)-type molecules with excessive bystander actions and susceptibility to efflux pumps, or charged and fewer permeable monomethyl auristatin F (MMAF) analogues with low bystander actions and resistance to efflux pumps. Herein, we report the event of novel auristatins that mix the attributes of every class by having each bystander exercise and cytotoxicity on multidrug-resistant (MDR+) cell traces.
Construction-based design targeted on the hydrophobic functionalization of the N-terminal N-methylvaline of the MMAF scaffold to extend cell permeability. The ensuing structure-activity relationships of the brand new auristatins display that optimization of hydrophobicity and construction can result in extremely lively free medication and antibody-drug conjugates with in vivo bystander actions. Tembusu virus (TMUV) causes illness in poultry, particularly in geese, leading to abnormality in egg manufacturing and with excessive morbidity and mortality, leading to nice loss in duck farming trade in China and Southeast Asia.
Earlier research on the pathogenesis of TMUV an infection have been principally carried out in poultry, with a number of research being undertaken in mice. Whereas TMUV doesn’t trigger illness in people, it has been reported that antibodies in opposition to TMUV have been present in serum samples from duck farmers, and thus knowledge on TMUV an infection in people is proscribed, and the pathogenesis is unclear.
Past Blocking: Engineering RNAi-Mediated Focused Immune Checkpoint Nanoblocker Allows T-Cell-Impartial Most cancers Therapy
The emergence of immune checkpoint blockade to activate host T cells to assault tumor cells has revolutionized the most cancers remedy panorama over the previous decade. Nevertheless, sustained response has solely been achieved in a small proportion of sufferers. This may be attributed to physiological boundaries, comparable to T-cell heterogeneity and immunosuppressive tumor microenvironments. To this may be added obstacles intrinsic to conventional antibody-driven blockade strategies, together with the shortcoming to inhibit checkpoint translocation from cytoplasm, systemic immune toxicity, and “chunk again” impact on T cells.
Utilizing non-small cell lung most cancers (NSCLC) because the most cancers mannequin, right here we report an unconventional, but highly effective, tumor-targeted checkpoint blocking technique by RNAi nanoengineering for T-cell-independent most cancers remedy. Not like antibodies, such nanoblocker silences each membranous and cytoplasmic PD-L1 in most cancers cells, thus eliminating the binding step. Furthermore, it’s demonstrated that silencing of PD-L1 by the nanoblocker may cause the direct programmed cell loss of life of NSCLC H460 cells, with out the necessity of T-cell intervention.
Goat major acute phase protein (MAP) ELISA kit |
E06M0379-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Goat major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat major acute phase protein (MAP) ELISA kit |
E06M0379-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Goat major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat major acute phase protein (MAP) ELISA kit |
E06M0379-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Goat major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit major acute phase protein (MAP) ELISA kit |
E04M0379-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit major acute phase protein (MAP) ELISA kit |
E04M0379-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit major acute phase protein (MAP) ELISA kit |
E04M0379-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human major acute phase protein (MAP) ELISA kit |
E01M0379-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Human major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human major acute phase protein (MAP) ELISA kit |
E01M0379-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human major acute phase protein (MAP) ELISA kit |
E01M0379-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Human major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse major acute phase protein (MAP) ELISA kit |
E03M0379-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Mouse major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse major acute phase protein (MAP) ELISA kit |
E03M0379-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Mouse major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse major acute phase protein (MAP) ELISA kit |
E03M0379-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Mouse major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Porcine MAP(major acute phase protein) ELISA Kit |
EP0218 |
FN Test |
96T |
EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Pig;Sensitivity: 0.938 ng/ml |
Monkey major acute phase protein (MAP) ELISA kit |
E09M0379-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Monkey major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey major acute phase protein (MAP) ELISA kit |
E09M0379-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Monkey major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey major acute phase protein (MAP) ELISA kit |
E09M0379-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Monkey major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat major acute phase protein (MAP) ELISA kit |
E02M0379-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rat major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat major acute phase protein (MAP) ELISA kit |
E02M0379-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rat major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat major acute phase protein (MAP) ELISA kit |
E02M0379-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rat major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog major acute phase protein (MAP) ELISA kit |
E08M0379-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Canine major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog major acute phase protein (MAP) ELISA kit |
E08M0379-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Canine major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog major acute phase protein (MAP) ELISA kit |
E08M0379-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Canine major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig major acute phase protein (MAP) ELISA kit |
E07M0379-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Porcine major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig major acute phase protein (MAP) ELISA kit |
E07M0379-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Porcine major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig major acute phase protein (MAP) ELISA kit |
E07M0379-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Porcine major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Bovine major acute phase protein(MAP)ELISA Kit |
YLA0385BO-96T |
Shanghai YL Biotech |
96T |
EUR 618.75 |
Cat Serum Amyloid A (SAA) Protein |
abx670164-01mg |
Abbexa |
0.1 mg |
EUR 1144.8 |
|
Guinea pig major acute phase protein (MAP) ELISA kit |
E05M0379-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Guinea pig major acute phase protein (MAP) ELISA kit |
E05M0379-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Guinea pig major acute phase protein (MAP) ELISA kit |
E05M0379-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Guinea pig major acute phase protein (MAP) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Porcine Major acute phase proteins(MAP)ELISA Kit |
YLA0333PO-48T |
Shanghai YL Biotech |
48T |
EUR 502.5 |
Porcine Major acute phase proteins(MAP)ELISA Kit |
YLA0333PO-96T |
Shanghai YL Biotech |
96T |
EUR 618.75 |
MAP ELISA Kit| Porcine major acute phase protein ELISA Kit |
EF016757 |
Lifescience Market |
96 Tests |
EUR 826.8 |
Human Catalase (CAT) ELISA Kit |
DLR-CAT-Hu-48T |
DL Develop |
48T |
EUR 529.2 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Human Catalase (CAT) ELISA Kit |
DLR-CAT-Hu-96T |
DL Develop |
96T |
EUR 684 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Mouse Catalase (CAT) ELISA Kit |
DLR-CAT-Mu-48T |
DL Develop |
48T |
EUR 632.4 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Mouse Catalase (CAT) ELISA Kit |
DLR-CAT-Mu-96T |
DL Develop |
96T |
EUR 825.6 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Rat Catalase (CAT) ELISA Kit |
DLR-CAT-Ra-48T |
DL Develop |
48T |
EUR 658.8 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Rat Catalase (CAT) ELISA Kit |
DLR-CAT-Ra-96T |
DL Develop |
96T |
EUR 861.6 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Catalase (CAT) in samples from serum, plasma, tissue homogenates or other biological fluids. |
Human Catalase (CAT) ELISA Kit |
RD-CAT-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 523.2 |
Human Catalase (CAT) ELISA Kit |
RD-CAT-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 721.2 |
Mouse Catalase (CAT) ELISA Kit |
RD-CAT-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 639.6 |
Mouse Catalase (CAT) ELISA Kit |
RD-CAT-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 888 |
Rat Catalase (CAT) ELISA Kit |
RD-CAT-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 668.4 |
Rat Catalase (CAT) ELISA Kit |
RD-CAT-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 930 |
Human Catalase (CAT) ELISA Kit |
RDR-CAT-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 546 |
Human Catalase (CAT) ELISA Kit |
RDR-CAT-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 754.8 |
Mouse Catalase (CAT) ELISA Kit |
RDR-CAT-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 668.4 |
Mouse Catalase (CAT) ELISA Kit |
RDR-CAT-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 928.8 |
Rat Catalase (CAT) ELISA Kit |
RDR-CAT-Ra-48Tests |
Reddot Biotech |
48 Tests |
EUR 699.6 |
Rat Catalase (CAT) ELISA Kit |
RDR-CAT-Ra-96Tests |
Reddot Biotech |
96 Tests |
EUR 973.2 |
Bovine Serum Amyloid A (SAA) ELISA Kit |
DLR-SAA-b-48T |
DL Develop |
48T |
EUR 656.4 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Serum Amyloid A (SAA) in samples from serum, plasma or other biological fluids. |
Bovine Serum Amyloid A (SAA) ELISA Kit |
DLR-SAA-b-96T |
DL Develop |
96T |
EUR 858 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Bovine Serum Amyloid A (SAA) in samples from serum, plasma or other biological fluids. |
Human Serum Amyloid A (SAA) ELISA Kit |
DLR-SAA-Hu-48T |
DL Develop |
48T |
EUR 574.8 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Serum Amyloid A (SAA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Human Serum Amyloid A (SAA) ELISA Kit |
DLR-SAA-Hu-96T |
DL Develop |
96T |
EUR 745.2 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Serum Amyloid A (SAA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Serum Amyloid A (SAA) ELISA Kit |
DLR-SAA-Mu-48T |
DL Develop |
48T |
EUR 586.8 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Serum Amyloid A (SAA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Mouse Serum Amyloid A (SAA) ELISA Kit |
DLR-SAA-Mu-96T |
DL Develop |
96T |
EUR 762 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Serum Amyloid A (SAA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rabbit Serum Amyloid A (SAA) ELISA Kit |
DLR-SAA-Rb-48T |
DL Develop |
48T |
EUR 609.6 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rabbit Serum Amyloid A (SAA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Rabbit Serum Amyloid A (SAA) ELISA Kit |
DLR-SAA-Rb-96T |
DL Develop |
96T |
EUR 793.2 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rabbit Serum Amyloid A (SAA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
Bovine Serum Amyloid A (SAA) ELISA Kit |
RD-SAA-b-48Tests |
Reddot Biotech |
48 Tests |
EUR 666 |
Bovine Serum Amyloid A (SAA) ELISA Kit |
RD-SAA-b-96Tests |
Reddot Biotech |
96 Tests |
EUR 925.2 |
Human Serum Amyloid A (SAA) ELISA Kit |
RD-SAA-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 573.6 |
Human Serum Amyloid A (SAA) ELISA Kit |
RD-SAA-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 794.4 |
Mouse Serum Amyloid A (SAA) ELISA Kit |
RD-SAA-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 586.8 |
Mouse Serum Amyloid A (SAA) ELISA Kit |
RD-SAA-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 812.4 |
Rabbit Serum Amyloid A (SAA) ELISA Kit |
RD-SAA-Rb-48Tests |
Reddot Biotech |
48 Tests |
EUR 613.2 |
Rabbit Serum Amyloid A (SAA) ELISA Kit |
RD-SAA-Rb-96Tests |
Reddot Biotech |
96 Tests |
EUR 850.8 |
Bovine Serum Amyloid A (SAA) ELISA Kit |
RDR-SAA-b-48Tests |
Reddot Biotech |
48 Tests |
EUR 696 |
Bovine Serum Amyloid A (SAA) ELISA Kit |
RDR-SAA-b-96Tests |
Reddot Biotech |
96 Tests |
EUR 968.4 |
Human Serum Amyloid A (SAA) ELISA Kit |
RDR-SAA-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 600 |
Human Serum Amyloid A (SAA) ELISA Kit |
RDR-SAA-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 830.4 |
Mouse Serum Amyloid A (SAA) ELISA Kit |
RDR-SAA-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 613.2 |
Mouse Serum Amyloid A (SAA) ELISA Kit |
RDR-SAA-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 850.8 |
Rabbit Serum Amyloid A (SAA) ELISA Kit |
RDR-SAA-Rb-48Tests |
Reddot Biotech |
48 Tests |
EUR 640.8 |
Rabbit Serum Amyloid A (SAA) ELISA Kit |
RDR-SAA-Rb-96Tests |
Reddot Biotech |
96 Tests |
EUR 890.4 |
Anti-Cat SAA Protein Antibody | MSAA-20A-1C12 |
MSAA-20A-1C12 |
Immunology Consultants Laboratory |
1.0 mg |
EUR 637 |
Description: Anti-Cat SAA Protein Antibody | MSAA-20A-1C12 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
Anti-Cat SAA Protein Antibody | MSAA-20A-3A5 |
MSAA-20A-3A5 |
Immunology Consultants Laboratory |
1.0 mg |
EUR 637 |
Description: Anti-Cat SAA Protein Antibody | MSAA-20A-3A5 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
Anti-Cat SAA Protein Antibody | MSAA-20A-4B2 |
MSAA-20A-4B2 |
Immunology Consultants Laboratory |
1.0 mg |
EUR 637 |
Description: Anti-Cat SAA Protein Antibody | MSAA-20A-4B2 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed |
ELISA-1 |
Alpha Diagnostics |
1 |
EUR 242.4 |
TruStrip RDT Human Serum Amyloid A (SAA) Rapid Test cards, 10 tests/pack |
SAA-RDT-10 |
Alpha Diagnostics |
1 pack |
EUR 205.2 |
TruStrip RDT Human Serum Amyloid A (SAA) Rapid Test cards, 25 tests/pack |
SAA-RDT-25 |
Alpha Diagnostics |
1 pack |
EUR 351.6 |
SAA-PEG-SAA |
abx085047-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 543.6 |
|
SAA-PEG-SAA |
abx085047-1kDa1g |
Abbexa |
1 kDa; 1 g |
EUR 543.6 |
|
SAA-PEG-SAA |
abx085047-20kDa1g |
Abbexa |
20 kDa; 1 g |
EUR 543.6 |
|
SAA-PEG-SAA |
abx085047-2kDa1g |
Abbexa |
2 kDa; 1 g |
EUR 543.6 |
|
SAA Protein |
abx060299-100ug |
Abbexa |
100 ug |
EUR 994.8 |
|
Recombinant Trypanosoma Cruzi Shed-acute-phase-antigen Protein (aa 61-460) (Yeast) [His] |
VAng-Wyb8481-100g |
Creative Biolabs |
100 µg |
EUR 5652 |
Description: Trypanosoma Cruzi Shed-acute-phase-antigen protein, recombinant protein. |
Recombinant Trypanosoma Cruzi Shed-acute-phase-antigen Protein (aa 61-460) (Yeast) [His] |
VAng-Wyb8481-500g |
Creative Biolabs |
500 µg |
EUR 14743.2 |
Description: Trypanosoma Cruzi Shed-acute-phase-antigen protein, recombinant protein. |
SAA-PEG-SAA,10K |
33-HO015015-10K |
Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
SAA-PEG-SAA,1K |
33-HO015015-1K |
Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
SAA-PEG-SAA,20K |
33-HO015015-20K |
Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
SAA-PEG-SAA,2K |
33-HO015015-2K |
Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
SAA-PEG-SAA,3.4K |
33-HO015015-3.4K |
Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
SAA-PEG-SAA,5K |
33-HO015015-5K |
Biochempeg |
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
SAA |
E64C01201 |
EnoGene |
20ug |
EUR 458.4 |
Recombinant Trypanosoma Cruzi Shed-acute-phase-antigen Protein (aa 61-460) (E. coli) [His] |
VAng-Wyb8480-100g |
Creative Biolabs |
100 µg |
EUR 4002 |
Description: Trypanosoma Cruzi Shed-acute-phase-antigen protein, recombinant protein. |
Recombinant Trypanosoma Cruzi Shed-acute-phase-antigen Protein (aa 61-460) (E. coli) [His] |
VAng-Wyb8480-500g |
Creative Biolabs |
500 µg |
EUR 9794.4 |
Description: Trypanosoma Cruzi Shed-acute-phase-antigen protein, recombinant protein. |
Human SAA ELISA Kit |
DEIA450 |
Creative Diagnostics |
96T |
EUR 1272 |
Description: ThisHuman SAA ELISA Kit is to be used for the in vitro quantitative determinationof human serum amyloid A (SAA) concentrations in serum, plasma, cell culture supernatant, and other biological fluids. |
Porcine SAA ELISA Kit |
EPS0235 |
Abclonal |
96Tests |
EUR 625.2 |
Rabbit SAA ELISA Kit |
ERTS0235 |
Abclonal |
96Tests |
EUR 625.2 |
Rat SAA ELISA Kit |
ERS0235 |
Abclonal |
96Tests |
EUR 625.2 |
Goat SAA ELISA Kit |
EGTS0235 |
Abclonal |
96Tests |
EUR 625.2 |
Monkey SAA ELISA Kit |
EMKS0235 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse SAA ELISA Kit |
EMS0235 |
Abclonal |
96Tests |
EUR 625.2 |
Human SAA ELISA Kit |
EHS0235 |
Abclonal |
96Tests |
EUR 625.2 |
Bovine SAA ELISA Kit |
EBS0235 |
Abclonal |
96Tests |
EUR 625.2 |
Chicken SAA ELISA Kit |
ECKS0235 |
Abclonal |
96Tests |
EUR 625.2 |
Anserini SAA ELISA Kit |
EAS0235 |
Abclonal |
96Tests |
EUR 625.2 |
Canine SAA ELISA Kit |
ECS0235 |
Abclonal |
96Tests |
EUR 625.2 |
Sheep SAA ELISA Kit |
ESS0235 |
Abclonal |
96Tests |
EUR 625.2 |
Human SAA/LDL Complex(SAA/LDL Complex)ELISA Kit |
YLA0855HU-96T |
Shanghai YL Biotech |
96T |
EUR 562.5 |
SAA antibody |
10-7959 |
Fitzgerald |
500 ug |
EUR 418.8 |
Description: Mouse monoclonal SAA antibody |
SAA antibody |
10-7960 |
Fitzgerald |
500 ug |
EUR 418.8 |
Description: Mouse monoclonal SAA antibody |
SAA antibody |
20-1715 |
Fitzgerald |
1 ml |
EUR 165.6 |
Description: Goat polyclonal SAA antibody |
SAA antibody |
10R-10351 |
Fitzgerald |
100 ug |
EUR 522 |
Description: Mouse monoclonal SAA antibody |
In vivo outcomes from xenograft tumor fashions additional display that tumor-homing peptide modification permits the nanoblocker to build up within the tumor tissue, downregulate the PD-L1 expression, and inhibit the tumor development extra effectively than the nontargeted group. These findings might provide an efficient means towards overcoming boundaries in opposition to conventional checkpoint blockade and supply completely different insights into the molecular mechanism(s) underlying immunotherapy.